SCHOTT Pharma AG & Co. KGaA Financial Flexibility Index
SCHOTT Pharma AG & Co. KGaA financial flexibility index. SCHOTT Pharma AG & Co. KGaA (1SXP) has a Financial Flexibility Index of 0.22x as of September 2024. Free cash flow of €140.66 Million (operating CF €75.97 Million minus capex €64.68 Million) represents 0% of total liabilities (€650.00 Million). Explore 1SXP capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of SCHOTT Pharma AG & Co. KGaA (2020–2024)
Financial flexibility index of SCHOTT Pharma AG & Co. KGaA from 2020 to 2024. Historical Financial Flexibility Index trend for SCHOTT Pharma AG & Co. KGaA across 5 annual periods. Check SCHOTT Pharma AG & Co. KGaA investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
SCHOTT Pharma AG & Co. KGaA Financial Flexibility Index by Year (2020–2024)
SCHOTT Pharma AG & Co. KGaA financial flexibility index by year from 2020 to 2024. Year-by-year free cash flow to debt coverage for SCHOTT Pharma AG & Co. KGaA. For the full cash flow conversion analysis, see SCHOTT Pharma AG & Co. KGaA (1SXP) cash flow conversion.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.57x | €370.62 Million | €225.33 Million | €650.00 Million | ▼ -13.9% |
| 2023 | 0.66x | €357.18 Million | €181.65 Million | €539.65 Million | ▼ -3.6% |
| 2022 | 0.69x | €334.81 Million | €182.12 Million | €487.46 Million | ▼ -4.6% |
| 2021 | 0.72x | €230.84 Million | €132.21 Million | €320.48 Million | ▲ +6.5% |
| 2020 | 0.68x | €189.71 Million | €104.40 Million | €280.36 Million | — |